Statistics

Total Visits

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)64

Select a period of time:

Number of views in the range

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)17

Views

Views
July 202514
August 20250
September 20251
October 20250
November 20252
December 20250
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United States3
United Kingdom2
Argentina2
Colombia1
 

Top cities views

Views
Barnstaple1
Brasília1
Chicago1
Feira de Santana1
Mendoza1
Ocala1
Pelotas1
Piracicaba1
Poços de Caldas1
San Juan Bautista1